Premium
Atracurium for intubation in man
Author(s) -
STIRT J. A.,
KATZ R. L.,
SCHEHL D. L.,
LEE C.
Publication year - 1984
Publication title -
anaesthesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.839
H-Index - 117
eISSN - 1365-2044
pISSN - 0003-2409
DOI - 10.1111/j.1365-2044.1984.tb06434.x
Subject(s) - medicine , intubation , anesthesia , laryngoscopy , incidence (geometry) , tracheal intubation , surgery , physics , optics
Summary Atracurium is a new competitive neuromuscular blocking agent. We prospectively studied intubating conditions 2.5 minutes afer atracurium doses of 0.4 or 0.5 mg/kg. For comparison, we evaluated conditions 1 minute after suxamethonium 1.0 mg/kg, there being 10 patients in each group. The same anaesthetist evaluated conditions during laryngoscopy and intubation in all patients. Intubating conditions were excellent in 33% of patients receiving atracurium 0.4 mg/kg and 60% of those receiving atracurium 0.5 mg/kg after 2.5 minutes; conditions were excellent in 80% of patients 1 minute after suxamethonium. The incidence of successful intubation on the jrst attempt was 67%, 90%, and 100%. respectively, in the three groups. Atracurium may be a suitable alternative to suxamethonium when speed of intubation is not critical.